Veterinary Research (Feb 2018)

A novel CAV derived cell-penetrating peptide efficiently delivers exogenous molecules through caveolae-mediated endocytosis

  • Gaowei Hu,
  • Wenlv Zheng,
  • Ao Li,
  • Yaru Mu,
  • Mingyu Shi,
  • Tuofan Li,
  • Haitao Zou,
  • Hongxia Shao,
  • Aijian Qin,
  • Jianqiang Ye

DOI
https://doi.org/10.1186/s13567-018-0513-2
Journal volume & issue
Vol. 49, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Cell-penetrating peptide (CPP) is a promising cargo for delivering bioactive molecules. In this study, the N terminus of VP1 from chicken anemia virus, designated as CVP1, was found to carry enriched arginine residues with α-helix. By confocal imaging, flow cytometry and MTT assay, we identified CVP1 as a novel, safe and efficient CPP. CVP1-FITC peptide could entry different types of cells tested with dose dependence, but without cytotoxic effects. Compared with TAT-FITC peptide, the CVP1-FITC peptide showed much higher cell-penetrating activity. Moreover, CVP1 could successfully deliver β-glycosidase, poly (I:C) and plasmid into HCT116 cells. Inhibitors and temperature sensitivity analysis further indicated that the cell-penetrating activity of CVP1 was based on ATP-dependent and caveolae-mediated endocytosis. All these data demonstrate that CVP1 has efficient cell-penetrating activity and great potential for developing a novel delivery vector.